Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :923
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Sunitinib in metastatic renal cell carcinoma: Experience from single center study, efficacy and safety

Patel K B, Panchal H P, Karanwal A B, Parekh B B, Shah S, Prasad S

Year : 2016| Volume: 53| Issue : 1 | Page no: 118-122

   This article has been cited by
 
1 Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics
Svetlana Miroshnichenko,Olga Patutina
Frontiers in Pharmacology. 2019; 10
[Pubmed]  [Google Scholar] [DOI]
2 First-line tyrosine kinase inhibitors in metastatic renal cell carcinoma: A regional cancer center experience
AH Rudresha,Tamojit Chaudhuri,KC Lakshmaiah,GovindK Babu,D Lokanatha,LinuAbraham Jacob,MC Suresh Babu,KN Lokesh,LK Rajeev
Indian Journal of Cancer. 2017; 54(4): 626
[Pubmed]  [Google Scholar] [DOI]
3 Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
Caroline Randrup Hansen,Daniela Grimm,Johann Bauer,Markus Wehland,Nils Magnusson
International Journal of Molecular Sciences. 2017; 18(2): 461
[Pubmed]  [Google Scholar] [DOI]

 

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow